These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26528178)

  • 1. Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations.
    Rossi G; Tagliavini F
    Front Aging Neurosci; 2015; 7():192. PubMed ID: 26528178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features.
    Rossi G; Bastone A; Piccoli E; Morbin M; Mazzoleni G; Fugnanesi V; Beeg M; Del Favero E; Cantù L; Motta S; Salsano E; Pareyson D; Erbetta A; Elia AE; Del Sorbo F; Silani V; Morelli C; Salmona M; Tagliavini F
    Neurobiol Aging; 2014 Feb; 35(2):408-17. PubMed ID: 24018212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau physiology and pathomechanisms in frontotemporal lobar degeneration.
    Bodea LG; Eckert A; Ittner LM; Piguet O; Götz J
    J Neurochem; 2016 Aug; 138 Suppl 1(Suppl Suppl 1):71-94. PubMed ID: 27306859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction.
    Xia Y; Nasif L; Giasson BI
    J Neurochem; 2021 Jul; 158(2):455-466. PubMed ID: 33772783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
    Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
    Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative Disease Tauopathies.
    Creekmore BC; Watanabe R; Lee EB
    Annu Rev Pathol; 2024 Jan; 19():345-370. PubMed ID: 37832941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying therapies for tauopathies: agents in the pipeline.
    Panza F; Imbimbo BP; Lozupone M; Greco A; Seripa D; Logroscino G; Daniele A; Colosimo C
    Expert Rev Neurother; 2019 May; 19(5):397-408. PubMed ID: 30973276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
    Morelli F; Romeo M; Barzago MM; Bolis M; Mattioni D; Rossi G; Tagliavini F; Bastone A; Salmona M; Diomede L
    Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies.
    Brunden KR; Yao Y; Potuzak JS; Ferrer NI; Ballatore C; James MJ; Hogan AM; Trojanowski JQ; Smith AB; Lee VM
    Pharmacol Res; 2011 Apr; 63(4):341-51. PubMed ID: 21163349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Threonine
    Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
    Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal Lobar Dementia Mutant Tau Impairs Axonal Transport through a Protein Phosphatase 1γ-Dependent Mechanism.
    Combs B; Christensen KR; Richards C; Kneynsberg A; Mueller RL; Morris SL; Morfini GA; Brady ST; Kanaan NM
    J Neurosci; 2021 Nov; 41(45):9431-9451. PubMed ID: 34607969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration. An update on clinical, pathological and genetic findings.
    Tolnay M; Probst A
    Gerontology; 2001; 47(1):1-8. PubMed ID: 11244285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology.
    Hartnell IJ; Blum D; Nicoll JAR; Dorothee G; Boche D
    Brain; 2021 Apr; 144(3):724-745. PubMed ID: 33527991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.